Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression

Nucleic Acids Research

Volumn 34, Issue 22, 2006, Pages 6640-6652

  Budhram Mahadeo, Vishwanie S ^a   Bowen, Samantha ^a   Lee, Sonia ^a   Perez Sanchez, Christina ^b   Ensor, Elizabeth ^a   Morris, Peter J ^a   Latchman, David S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN BAX; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRN 3B PROTEIN; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; APOPTOSIS; ARTICLE; BINDING SITE; CELL CYCLE ARREST; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE TARGETING; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MOLECULAR CLONING; NERVE CELL CULTURE; NERVOUS SYSTEM DEVELOPMENT; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BINDING SITES; CELL CYCLE; CELL LINE; CELLS, CULTURED; HOMEODOMAIN PROTEINS; MICE; MICE, KNOCKOUT; NEURONS; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR BRN-3B; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 33845903036     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl878     Document Type: Article

References (65)

1. Budhram-Mahadeo,V.S. and Latchman,D.S. (2006) Targeting Brn-3b in breast cancer therapy. Expert Opin. Ther. Targets, 10, 15-25.
2. Theil,T., Zechner,U., Klett,C., Adolph,S. and Moroy,T. (1994) Chromosomal localization and sequences of the murine Brn-3 family of developmental control genes. Cytogenet. Cell Genet., 66, 267-271.
3. Lillycrop,K.A., Budhram-Mahadeo,V., Lakin,N.D., Terrenghi,G., Wood,J.N., Polak,J.M. and Latchman,D.S. (1992) A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells. Nucleic Acids Res., 20, 5093-5096.
4. Smith,M.D. and Latchman,D.S. (1996) The functionally antagonistic POU family transcription factors Brn-3a and Brn-3b show opposite changes in expression during the growth arrest and differentiation of human neuroblastoma cells. Int. J. Cancer, 67, 653-660.
5. Budhram-Mahadeo,V., Lillycrop,K.A. and Latchman,D.S. (1995) The levels of the antagonistic POU family transcription factors Brn-3a and Brn-3b in neuronal cells are regulated in opposite directions by serum growth factors. Neurosci. Lett., 185, 48-51.
6. Dennis,J.H., Budhram-Mahadeo,V. and Latchman,D.S. (2001) The Brn-3b POU family transcription factor regulates the cellular growth, proliferation, and anchorage dependence of MCF7 human breast cancer cells. Oncogene, 20, 4961-4971.
7. Budhram-Mahadeo,V., Ndisang,D., Ward,T., Weber,B.L. and Latchman,D.S. (1999) The Brn-3b POU family transcription factor represses expression of the BRCA-1 anti-oncogene in breast cancer cells. Oncogene, 18, 6684-6691.
8. Irshad,S., Pedley,R.B., Anderson,J., Latchman,D.S. and Budhram-Mahadeo,V. (2004) The Brn-3b transcription factor regulates the growth, behavior and invasiveness of human neuroblastoma cells in vitro and in vivo. J. Biol. Chem., 279, 21617-21627.
9. Erkman,L., McEvilly,R.J., Luo,L., Ryan,A.K., Hooshmand,F., O'Connell,S.M., Keithley,E.M., Rapaport,D.H., Ryan,A.F. and Rosenfeld,M.G. (1996) Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature, 381, 603-606.
10. Gan,L., Xiang,M., Zhou,L., Wagner,D.S., Klein,W.H. and Nathans,J. (1996) POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells. Proc. Natl Acad. Sci. USA, 93, 3920-3925.
11. Smith,M.D., Dawson,S.J. and Latchman,D.S. (1997) Inhibition of neuronal process outgrowth and neuronal specific gene activation by the Brn-3b transcription factor. J. Biol. Chem., 272, 1382-1388.
12. Morris,P.J., Lakin,N.D., Dawson,S.J., Ryabinin,A.E., Kilimann,M.W., Wilson,M.C. and Latchman,D.S. (1996) Differential regulation of genes encoding synaptic proteins by members of the Brn-3 subfamily of POU transcription factors. Brain Res. Mol. Brain Res., 43, 279-285.
13. Lakin,N.D., Morris,P.J., Theil,T., Sato,T.N., Moroy,T., Wilson,M.C. and Latchman,D.S. (1995) Regulation of neurite outgrowth and SNAP-25 gene expression by the Brn-3a transcription factor. J. Biol. Chem., 270, 15858-15863.
14. Ndisang,D., Faulkes,D.J., Gascoyne,D., Lee,S.A., Ripley,B.J., Sindos,M., Singer,A., Budhram-Mahadeo,V., Cason,J. and Latchman,D.S. (2006) Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a. Oncogene, 25, 51-60.
15. Smith,M.D., Morris,P.J., Dawson,S.J., Schwartz,M.L., Schlaepfer,W.W. and Latchman,D.S. (1997) Coordinate induction of the three neurofilament genes by the Brn-3a transcription factor. J. Biol. Chem., 272, 21325-21333.
16. Smith,M.D., Dawson,S.J. and Latchman,D.S. (1997) The Brn-3a transcription factor induces neuronal process outgrowth and the coordinate expression of genes encoding synaptic proteins. Mol. Cell Biol., 17, 345-354.
17. Budhram-Mahadeo,V., Morris,P.J., Lakin,N.D., Theil,T., Ching,G.Y., Lillycrop,K.A., Moroy,T., Liem,R.K. and Latchman,D.S. (1995) Activation of the alpha-internexin promoter by the Brn-3a transcription factor is dependent on the N-terminal region of the protein. J. Biol. Chem., 270, 2853-2858.
18. Samady,L., Dennis,J., Budhram-Mahadeo,V. and Latchman,D.S. (2004) Activation of CDK4 Gene Expression in Human Breast Cancer Cells by the Brn-3b POU Family Transcription Factor. Cancer Biol. Ther., 3, 317-323.
19. Yang,X. and Lippman,M.E. (1999) BRCA1 and BRCA2 in breast cancer. Breast Cancer Res. Treat., 54, 1-10.
20. Bertwistle,D. and Ashworth,A. (1998) Functions of the BRCA1 and BRCA2 genes. Curr. Opin. Genet. Dev., 8, 14-20.
21. Thompson,M.E., Jensen,R.A., Obermiller,P.S., Page,D.L. and Holt,J.T. (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet., 9, 444-450.
22. Budhram-Mahadeo,V., Parker,M. and Latchman,D.S. (1998) POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element. Mol. Cell Biol., 18, 1029-1041.
23. Lee,S.A., Ndisang,D., Patel,C., Dennis,J.H., Faulkes,D.J., D'Arrigo,C., Samady,L., Farooqui-Kabir,S., Heads,R.J., Latchman,D.S. et al. (2005) Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter. Cancer Res, 65, 3072-3080.
24. Latchman,D.S. (1998) The Brn-3a transcription factor. Int. J. Biochem. Cell Biol., 30, 1153-1157.
25. Budhram-Mahadeo,V., Morris,P.J., Smith,M.D., Midgley,C.A., Boxer,L.M. and Latchman,D.S. (1999) p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J. Biol. Chem., 274, 15237-15244.
26. Hudson,C.D., Podesta,J., Henderson,D., Latchman,D.S. and Budhram-Mahadeo,V. (2004) Coexpression of Brn-3a POU protein with p53 in a population of neuronal progenitor cells is associated with differentiation and protection against apoptosis. J. Neurosci. Res., 78, 803-814.
27. Perez-Sanchez,C., Budhram-Mahadeo,V.S. and Latchman,D.S. (2002) Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter. Nucleic Acids Res., 30, 4872-4880.
28. (CIP1/Waf1). Oncogene, 21, 6123-6131.
29. Kaelin,W.G., Jr (1999) The p53 gene family. Oncogene, 18, 7701-7705.
30. El Deiry,W.S. (1998) Regulation of p53 downstream genes. Semin. Cancer Biol., 8, 345-357.
31. Oren,M. (2003) Decision making by p53: Life, death and cancer. Cell Death Differ., 10, 431-442.
32. Bergamaschi,D., Samuels,Y., Jin,B., Duraisingham,S., Crook,T. and Lu,X. (2004) ASPP1 and ASPP2: Common activators of p53 family members. Mol Cell Biol., 24, 1341-1350.
33. Samuels-Lev,Y., O'Connor,D.J., Bergamaschi,D., Trigiante,G., Hsieh,J.K., Zhong,S., Campargue,I., Naumovski,L., Crook,T. and Lu,X. (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell, 8, 781-794.
34. Eeles,R.A., Bartkova,J., Lane,D.P. and Bartek,J. (1993) The role of TP53 in breast cancer development. Cancer Surv., 18, 57-75.
35. Taylor,W.R. and Stark,G.R. (2001) Regulation of the G2/M transition by p53 3. Oncogene, 20, 1803-1815.
36. Hudson,C.D., Morris,P.J., Latchman,D.S. and Budhram-Mahadeo,V.S. (2005) Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate. J. Biol. Chem., 280, 11851-11858.
37. Patel,T.D., Jackman,A., Rice,F.L., Kucera,J. and Snider,W.D. (2000) Development of sensory neurons in the absence of NGF/TrkA signaling in vivo 1. Neuron, 25, 345-357.
38. White,F.A., Keller-Peck,C.R., Knudson,C.M., Korsmeyer,S.J. and Snider,W.D. (1998) Widespread elimination of naturally occurring neuronal death in Bax-deficient mice. J. Neurosci., 18, 1428-1439.
39. Ensor,E., Mathews,K., Payne,S. and Latchman,D.S. (2003) Sensory neurons from mice lacking the Brn-3b POU family transcription factor are resistant to death-inducing stimuli both in vitro and in vivo. Brain Res. Mol. Brain Res., 117, 206-212.
40. Ensor,E., Smith,M.D. and Latchman,D.S. (2001) The BRN-3A transcription factor protects sensory but not sympathetic neurons from programmed cell death/apoptosis. J. Biol. Chem., 276, 5204-5212.
41. Xiang,M. (1998) Requirement for Brn-3b in early differentiation of postmitotic retinal ganglion cell precursors. Dev.Biol., 197, 155-169.
42. Vousden,K.H. and Lu,X. (2002) Live or let die: The cell's response to p53. Nature Rev. Cancer, 2, 594-604.
43. Benchimol,S. (2001) p53-dependent pathways of apoptosis. Cell Death Differ., 8, 1049-1051.
44. Carr,A.M. (2000) Cell cycle. Piecing together the p53 puzzle [comment]. Science, 287, 1765-1766.
45. Hunter,T. and Pines,J. (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell, 79, 573-582.
46. McEvilly,R.J., Erkman,L., Luo,L., Sawchenko,P.E., Ryan,A.F. and Rosenfeld,M.G. (1996) Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons. Nature, 384, 574-577.
47. Xiang,M., Gan,L., Zhou,L., Klein,W.H. and Nathans,J. (1996) Targeted deletion of the mouse POU domain gene Brn-3a causes selective loss of neurons in the brainstem and trigeminal ganglion, uncoordinated limb movement, and impaired suckling. Proc. Natl Acad. Sci. USA, 93, 11950-11955.
48. Gan,L., Wang,S.W., Huang,Z. and Klein,W.H. (1999) POU domain factor Brn-3b is essential for retinal ganglion cell differentiation and survival but not for initial cell fate specification. Dev. Biol., 210, 469-480.
49. Miller,C.W., Chumakov,A., Said,J., Chen,D.L., Aslo,A. and Koeffler,H.P. (1993) Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription. Oncogene, 8, 1815-1824.
50. Hughes,C., Gomez-Caminero,A., Benkendorf,J., Kerner,J., Isaacs,C., Barter,J. and Lerman,C. (1997) Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ. Couns., 32, 51-62.
51. Eizenberg,O., Faber-Elman,A., Gottlieb,E., Oren,M., Rotter,V. and Schwartz,M. (1996) p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol. Cell Biol., 16, 5178-5185.
52. Ko,L.J. and Prives,C. (1996) p53: Puzzle and paradigm. Genes Dev., 10, 1054-1072.
53. Deckwerth,T.L., Elliott,J.L., Knudson,C.M., Johnson,E.M., Jr, Snider,W.D. and Korsmeyer,S.J. (1996) BAX is required for neuronal death after trophic factor deprivation and during development. Neuron, 17, 401-411.
54. Shindler,K.S., Latham,C.B. and Roth,K.A. (1997) Bax deficiency prevents the increased cell death of immature neurons in bcl-x-deficient mice. J. Neurosci., 17, 3112-3119.
55. Sato,N., Sakuma,C., Sato,Y., Gould,T.W., Oppenheim,R.W. and Yaginuma,H. (2006) Distinct susceptibility of developing neurons to death following Bax overexpression in the chicken embryo 1. Cell Death Differ., 13, 435-445.
56. Tweddle,D.A., Pearson,A.D., Haber,M., Norris,M.D., Xue,C., Flemming,C. and Lunec,J. (2003) The p53 pathway and its inactivation in neuroblastoma. Cancer Lett., 197, 93-98.
57. Samady,L., Faulkes,D.J., Budhram-Mahadeo,V., Ndisang,D., Potter,E., Brabant,G. and Latchman,D.S. (2005) The Brn-3b POU family transcription factor represses plakoglobin gene expression in human breast cancer cells. Int. J. Cancer, 187 (4), 869-878.
58. Secombe,J., Pierce,S.B. and Eisenman,R.N. (2004) Myc: A weapon of mass destruction. Cell, 117, 153-156.
59. Hermeking,H. and Eick,D. (1994) Mediation of c-Myc-induced apoptosis by p53. Science, 265, 2091-2093.
60. Oda,E., Ohki,R., Murasawa,H., Nemoto,J., Shibue,T., Yamashita,T., Tokino,T., Taniguchi,T. and Tanaka,N. (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science, 288, 1053-1058.
61. Maniatis,T., Fritch,E.F. and Sambrook,J. (1990) Molecular Cloning: A Laboratory Manual 2nd ed. Cold Spring Harbour Laboratories, Cold Spring Harbour.
62. Wood,J.N., Bevan,S.J., Coote,P.R., Dunn,P.M., Harmar,A., Hogan,P., Latchman,D.S., Morrison,C., Rougon,G., Theveniau,M. et al. (1990) Novel cell lines display properties of nociceptive sensory neurons. Proc. Biol. Sci., 241, 187-194.
63. Budhram-Mahadeo,V., Lillycrop,K.A. and Latchman,D.S. (1994) Cell cycle arrest and morphological differentiation can occur in the absence of apoptosis in a neuronal cell line. Neurosci. Lett., 165, 18-22.
64. Komarov,P.G., Komarova,E.A., Kondratov,R.V., Christov-Tselkov,K., Coon,J.S., Chernov,M.V. and Gudkov,A.V. (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science, 285, 1733-1737.
65. Budhram-Mahadeo,V., Morris,P., Ndisang,D., Irshad,S., Lozano,G., Pedley,B. and Latchman,D.S. (2002) The Brn-3a POU family transcription factor stimulates p53 gene expression in human and mouse tumour cells. Neurosci. Lett., 334, 1-4.